Fact check: Who are the founders and investors behind Outro antidepressant withdrawal company?

1. Summary of the results

The founding team of Outro, launched in 2024, consists of:

• Dr. Mark Horowitz, confirmed as co-founder by multiple sources ^{[1] [2] [3]}
• Adele Framer, identified as co-founder ^[2]
• Brandon Goode, also named as co-founder ^[3]

The company operates as a cash-pay telehealth service focusing on antidepressant withdrawal support, currently available in seven US states ^[3]. None of the sources explicitly name any investors in the company.

2. Missing context/alternative viewpoints

Several important contextual elements are worth noting:

• The founders' personal experiences with antidepressant withdrawal shaped the company's mission - particularly Dr. Horowitz's experience during his Ph.D. studies ^[1]
• The company employs key medical professionals, including:
• Charlotte, a nurse practitioner
• Dr. Shapiro, a board-certified psychiatrist ^[2]
• The company specifically focuses on science-based tapering methods ^[1]
• The service is currently in beta mode since summer 2024 ^[3]

3. Potential misinformation/bias in the original statement

The original question assumes there might be significant investor backing, but the available sources don't confirm any external investment. This could indicate either:

• The company might be self-funded or early-stage
• Investment information might be intentionally kept private
• The founders might be leveraging their medical and professional backgrounds rather than external capital

It's worth noting that as a cash-pay telehealth service ^[3], the company's business model and funding structure might differ from traditional healthcare startups that often rely heavily on venture capital.